Please login to the form below

Not currently logged in
Email:
Password:

stem cell therapy

This page shows the latest stem cell therapy news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

The 2016 Orphan Drug Award was won by Holoclar, which in 2015 became the first stem cell therapy to receive European marketing approval. ... The therapy is used to treat moderate-to-severe forms of limbal stem cell deficiency (LSCD), a rare eye condition

Latest news

More from news
Approximately 3 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Takeda moves in neurodegenerative diseases and stem cell therapy. Meanwhile Takeda, ranked 4. ... A few days later Takeda announced it was paying $628m (82% share price premium) to buy Belgian company TiGenix NV and its lead asset Cx601 (darvadstrocel),

  • Pharma deals continue to slide Pharma deals continue to slide

    This referred to the CAR-T therapy, Kymriah, from Novartis for treating a form of acute lymphoblastic leukaemia in children and young adults. ... 425 (upfront 80). Calimmune (US). CSL (AU). Company acquisition. Preclinical haematopoietic stem cell

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    Mock assessment of a CAR-T therapy. The hypothetical CAR-T therapy was tested in two different profiles: as a bridge to haematopoietic stem cell transplantation or as a curative therapy. ... If so, how much of the per-patient price could the cell therapy

  • Heart failure therapy embarks on a new era Heart failure therapy embarks on a new era

    Stem cell therapy for HF is currently being led by the likes of Bioheart (recently renamed US Stem Cell), which has muscle stem cell therapy candidate Myocell in a phase III ... trial; Mesoblast/Teva with allogenic mesenchymal stem cell therapy Neofuse;

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    225. Athersys / Chugai. Licence and collaboration Japan. Phase 2 stem cell therapy for treatment of ischaemic stroke.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Dr Jay Stout moves from Merck to SanBio Dr Jay Stout moves from Merck to SanBio

    In this role, he is responsible for all production-related operations, including clinical cell preparation, final quality assurance and process development. ... He is perhaps the individual with the greatest experience in the world in manufacturing

  • Plasticell names Aaron Chuang as chief scientific officer Plasticell names Aaron Chuang as chief scientific officer

    Chuang was an industrial advisor on high profile stem cell initiatives including UK Stem Cell Initiative, UK Cell Therapy Catapult and the California Institute of Regenerative Medicine. ... He was also prominent in establishing GSK's alliance with the

  • ReNeuron makes shifts and additions to senior team ReNeuron makes shifts and additions to senior team

    UK-based stem cell therapy company ReNeuron has announced a number of board and senior management changes. ... Dr Randolph Corteling has been promoted to head of research from his current role of head of cell biology after joining in 2007.

  • ReNeuron appoints new CEO ReNeuron appoints new CEO

    ReNeuron appoints new CEO. Olav Hellebø joins from Clavis Pharma. UK-based stem cell therapy company ReNeuron Group has appointed Olav Hellebø as its new CEO with immediate effect. ... ReNeuron's stem cell therapy candidates, will be the best way to

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics